Effects of selective β1-adrenoceptor blockade on cardiovascular and renal function and circulating cytokines in ovine hyperdynamic sepsis.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4262191)

Published in Crit Care on November 21, 2014

Authors

Paolo Calzavacca1,2,3, Yugeesh R Lankadeva4,5, Simon R Bailey6, Michael Bailey7, Rinaldo Bellomo8,9, Clive N May10

Author Affiliations

1: Florey Institute of Neuroscience and Mental Health, University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia. p.calzavacca@gmail.com.
2: Department of Intensive Care and Department of Medicine, Austin Health, 145 Studley Road, Heidelberg, VIC, 3084, Australia. p.calzavacca@gmail.com.
3: Department of Anaesthesia and Intensive Care, AO Melegnano, PO Uboldo, Cernusco sul Naviglio, Italy. p.calzavacca@gmail.com.
4: Florey Institute of Neuroscience and Mental Health, University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia. yugeesh.lankadeve@monash.edu.
5: Department of Physiology, Monash University, Wellington Road, Clayton, VIC, 3800, Australia. yugeesh.lankadeve@monash.edu.
6: Faculty of Veterinary Science, University of Melbourne, Corner Park Drive and Flemington Road, Melbourne, VIC, 3052, Australia. bais@unimelb.edu.au.
7: Australian and New Zealand Intensive Care Research Centre, Monash University, Wellington Road, Clayton, VIC, 3800, Australia. Michael.Bailey@monash.edu.
8: Department of Intensive Care and Department of Medicine, Austin Health, 145 Studley Road, Heidelberg, VIC, 3084, Australia. Rinaldo.bellomo@austin.org.au.
9: The Australian and New Zealand Intensive Care Research Centre, 99 Commercial Road, Melbourne, VIC, 3004, Australia. Rinaldo.bellomo@austin.org.au.
10: Florey Institute of Neuroscience and Mental Health, University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia. clive.may@florey.edu.au.

Articles cited by this

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37

Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74

Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA (2013) 7.23

Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med (2007) 5.65

Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet (1998) 3.71

Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med (2007) 2.79

Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? Am J Respir Crit Care Med (2013) 2.65

Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med (1997) 2.58

Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study. Crit Care Med (2013) 1.81

Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med (2005) 1.73

Resilience to bacterial infection: difference between species could be due to proteins in serum. J Infect Dis (2010) 1.73

Renal blood flow in sepsis. Crit Care (2005) 1.59

Previous prescription of β-blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis. Crit Care Med (2012) 1.56

How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism. Br J Clin Pharmacol (1982) 1.51

Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med (1999) 1.46

Central sympatholytics prolong survival in experimental sepsis. Crit Care (2009) 1.37

Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats. Crit Care Med (2010) 1.30

Vital organ blood flow during hyperdynamic sepsis. Chest (2003) 1.19

The treatment of endotoxin shock by beta adrenergic blockade. Ann Surg (1969) 1.17

Myocardial dysfunction in septic shock: Part I. Clinical manifestation of cardiovascular dysfunction. J Cardiothorac Vasc Anesth (2001) 1.09

Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis. Surgery (2006) 1.03

Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model. Shock (2009) 1.01

beta-Adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis. Resuscitation (2006) 1.01

Participation of beta-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. J Recept Signal Transduct Res (1999) 0.94

Contribution of differently localized alpha 2- and beta-adrenoceptors in the modulation of TNF-alpha and IL-10 production in endotoxemic mice. Ann N Y Acad Sci (2000) 0.93

Association between inotrope treatment and 90-day mortality in patients with septic shock. Acta Anaesthesiol Scand (2013) 0.89

The treatment of shock with beta adrenergic blockade. Arch Surg (1972) 0.89

Sympathetic activation and tachycardia in lipopolysaccharide treated rats are temporally correlated and unrelated to the baroreflex. Auton Neurosci (2005) 0.85

Septic shock induces distinct changes in sympathetic nerve activity to the heart and kidney in conscious sheep. Am J Physiol Regul Integr Comp Physiol (2009) 0.84

Clinical and histopathological characterization of a large animal (ovine) model of collagen-induced arthritis. Vet Immunol Immunopathol (2014) 0.81

Effects of renal denervation on regional hemodynamics and kidney function in experimental hyperdynamic sepsis. Crit Care Med (2014) 0.77